Stiris Research Inc

Glioblastoma (GBM) standard of care hasn't changed in two decades. Not because no one's tried. Because the biology itself keeps outsmarting the science.

In Chapter 1 of , we break down why this tumor remains one of oncology's hardest problems to solve and why understanding that complexity is the starting point for designing trials that actually work.

Swipe to learn more ➡️

Today, we celebrate more than a country. We celebrate the passion, the collaboration, and the pride that unite us.

Happy Canada Day from all of us at Stiris!

Behind every successful clinical trial are participants and caregivers who feel supported, informed, and engaged.

Our Patient Caregiver Liaison (PCL) service helps create that connection: improving recruitment, strengthening retention, and enhancing the participant experience throughout the study journey.

Will you be attending ? We'd love to talk about how a more participant-centred approach can strengthen your next study, because it's not just about how fast we innovate, but how well that innovation truly benefits participants and caregivers.

Let's keep talking about why conversations with participants and caregivers matter in your studies. 📩 Email us at [email protected] to book a meeting with our experts.